- Home
- OESX vs TENX Comparison
OESX vs TENX Comparison
Compare OESX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OESX
- TENX
- Stock Information
- Founded
- OESX 1996
- TENX 1967
- Country
- OESX United States
- TENX United States
- Employees
- OESX N/A
- TENX N/A
- Industry
- OESX Building Products
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- OESX Consumer Discretionary
- TENX Health Care
- Exchange
- OESX Nasdaq
- TENX Nasdaq
- Market Cap
- OESX 32.5M
- TENX 27.3M
- IPO Year
- OESX 2007
- TENX N/A
- Fundamental
- Price
- OESX $8.26
- TENX $7.50
- Analyst Decision
- OESX Strong Buy
- TENX Strong Buy
- Analyst Count
- OESX 2
- TENX 4
- Target Price
- OESX $17.50
- TENX $16.67
- AVG Volume (30 Days)
- OESX 14.3K
- TENX 130.4K
- Earning Date
- OESX 11-05-2025
- TENX 11-12-2025
- Dividend Yield
- OESX N/A
- TENX N/A
- EPS Growth
- OESX N/A
- TENX N/A
- EPS
- OESX N/A
- TENX N/A
- Revenue
- OESX $79,389,000.00
- TENX N/A
- Revenue This Year
- OESX $6.70
- TENX N/A
- Revenue Next Year
- OESX $13.43
- TENX N/A
- P/E Ratio
- OESX N/A
- TENX N/A
- Revenue Growth
- OESX N/A
- TENX N/A
- 52 Week Low
- OESX $5.50
- TENX $3.25
- 52 Week High
- OESX $10.35
- TENX $7.91
- Technical
- Relative Strength Index (RSI)
- OESX 50.47
- TENX 82.09
- Support Level
- OESX $7.90
- TENX $6.34
- Resistance Level
- OESX $8.90
- TENX $7.88
- Average True Range (ATR)
- OESX 0.60
- TENX 0.34
- MACD
- OESX -0.17
- TENX 0.12
- Stochastic Oscillator
- OESX 19.07
- TENX 77.09
About OESX Orion Energy Systems Inc.
Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.